intelligence360

The Intelligent News Source

Tag: FoxEyes

FoxEyes has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, FoxEyes is raising up to $2,000,000.00 in new funding. Sources indicate that as part of senior management Founder and Director, Min Seo played a key…

intelligence360

Source: http://www.intelligence360.io/ and https://intelligence360.news/

Qure.ai, a global healthcare AI innovator, has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the US market and other geographies, increase investment in foundational AI models, and enable complementary med-tech company acquisitions. The Series D round saw the participation of new strategic and financial investors led by Lightspeed and 360 ONE Asset, joined by Merck Global Health Innovation Fund and Kae Capital. Existing investors also participated in the round, including Novo Holdings, HealthQuad, and TeamFund.

In a statement Prashant Warier, Co-founder and CEO of Qure.ai said, “Qure.ai has become a trusted medical imaging AI partner to hospitals and healthcare organizations around the world. Our work is helping to unlock clinical efficiencies and drive up the standard of care delivered to patients in the focus areas of TB, Lung Cancer and Stroke.” This Series D round is an exciting step forward in our journey and will propel us forward in our mission to reach a billion patients through our solutions.”

Founded in 2016, Qure.ai is on a mission to make healthcare more accessible and equitable globally. This has driven its AI solution development, positioning the company as the world’s most deployed healthcare AI. Qure.ai solutions are deployed in over 90 countries across 3000+ sites, powering the efficient identification and management of critical diseases. Their solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. Qure.ai is headquartered in Mumbai, with regional offices in New York, London, and Dubai.

Source: http://www.intelligence360.io/ and https://intelligence360.news/

The veterinary profession is facing a crisis of burnout, with 86% of veterinarians reporting severe stress levels. One of the compounding issues includes a frequently overlooked culprit: spending hours writing medical records. Scribenote, an AI-powered medical scribe for veterinarians, has raised $8.2M in seed funding to tackle this problem head-on. The company’s funding was led by Andreessen Horowitz (a16z), with additional participation from Inovia Capital, the Velocity Fund, and a line-up of angel investors.

Veterinarians have a legal responsibility to document every aspect of their interactions with clients, necessitating accurate and complete medical records. Unfortunately, with various types of appointments every 20 to 30 minutes of the day, documentation can be challenging and pile up quickly. Some veterinarians may see up to 30 patients in one day and there is rarely time to document between visits. This results in veterinarians working overtime during lunch and at the end of the day to type records.

Co-founded by Dr. Katie Gallagher, Alina Pavel, and Emily Merry, Scribenote records conversations between veterinarians and clients, and uses AI to automatically generate accurate medical records in just minutes. In addition to medical records and dental charts, various forms of client communication are also automated, allowing veterinary professionals to fully focus on patient care and building relationships with clients. By providing complete and detailed records of what was discussed, documentation struggles are reduced for an already overburdened Profession.

Load More... Subscribe